tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Hazlett, 55 are a BUY (88.71%), 6 are a HOLD (9.68%), 1 are a SELL (1.61%).
Analyst Robert Hazlett, currently employed carries an average stock price target met ratio of 23.68% that have a potential upside of 26.24% achieved within 128 days. Previously, Robert Hazlett worked at BTIG.
Robert Hazlett’s has documented 110 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AURA, Aura Biosciences at 08-Dec-2023.
Analyst best performing recommendations are on AXSM (AXSOME THERAPEUTICS).
The best stock recommendation documented was for AXSM (AXSOME THERAPEUTICS) at 12/17/2019. The price target of $97 was fulfilled within 3 days with a profit of $16.03 (19.8%) receiving and performance score of 65.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$89
$5.58 (6.69%)
$81
16 days ago
(04-Nov-2024)
9/9 (100%)
$2.02 (2.32%)
43
Buy
$100
$16.58 (19.88%)
$100
20 days ago
(31-Oct-2024)
18/24 (75%)
$15.25 (17.99%)
172
Buy
$95
$11.58 (13.88%)
$80
1 months 9 days ago
(11-Oct-2024)
3/4 (75%)
$19.24 (25.40%)
400
Buy
$108
$24.58 (29.47%)
$106
1 months 16 days ago
(04-Oct-2024)
18/21 (85.71%)
$35.11 (48.17%)
259
Buy
$130
$46.58 (55.84%)
$130
2 months ago
(20-Sep-2024)
18/29 (62.07%)
$52.39 (67.50%)
562
What Year was the first public recommendation made by Robert Hazlett?
